Merck Explains Parkinson’s Drug Shortage — Nearly a Year Later | BNET
Links shared publicly online about this topic.
- 927total visits
Merck Explains Parkinson’s Drug Shortage — Nearly a Year Later | BNET
bnet.com —
View full resource at bnet.com
Tags: Parkinson's Disease, Parkinson's Disease Medication, Disease and Condition, Drug, Sinemet, Merck & Co.
Most Recently Shared on August 23, 2010 at 2:16 pm By:
RT @Jim_Edwards: Merck Explains Parkinson's Drug Shortage -- Nearly a Year Later: ... http://bit.ly/bRp1ns
Also Shared By:
Bleeding risk clouds Merck's hopes for vorapaxar franchise - FierceBiotech
fiercebiotech.com — “Vorapaxar isn't shaping up to be the mega hit that Merck ($MRK) had hoped for. Once billed as a promising successor to warfarin, Merck was left to explain marginal benefits and a serious added Read more...” View full resource at fiercebiotech.com
Most Recently Shared on March 26, 2012 at 12:36 pm By:
John Carroll Health Communicator
Merck: I paid $41 billion for Schering-Plough and all I got was this added risk of bleeding. #biotech http://t.co/gKHAl2Bp
PolygenicBlog: The Ballooning Brain: Defective Genes May Explain Uncontrolled Brain Growth in Autism: Scientific American
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on March 23, 2012 at 9:26 pm By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter PhD, Doctor, Medical Technology, and Pharmacist
The Ballooning Brain: Defective Genes May Explain Uncontrolled Brain Growth in #Autism… http://t.co/9jixSgml
Neurology Reviews: Audiocast
neurologyreviews.com — “Neurology Reviews covers innovative and emerging news in neurology and neuroscience every month, with a focus on practical approaches to treating Parkinson's disease, epilepsy, headache, stroke, multiple sclerosis, Alzheimer's disease, and other neurologic disorders.” View full resource at neurologyreviews.com
Most Recently Shared on March 14, 2012 at 1:33 pm By:
Neurology Reviews Neurology and Health News
New audiocast: Robert Cowan, MD, Explains How Headache Specialists Can Learn Integrative Medical Techniques http://t.co/VBuOlRey #migraine
Gene that causes aggression in men under stress discovered
news-medical.net — “Scientists have found that “macho” gene that makes men behave more aggressively than women under stress. They say this one gene could explain why men have a 'fight or flight' response while women are more likely to try and defuse the situation. The study has been published in the journal BioEssays.” View full resource at news-medical.net
Most Recently Shared on March 12, 2012 at 12:00 am By:
Gene that causes aggression in men under stress discovered: Scientists have found that “macho” gene that makes m... http://t.co/R2aklWrY
Scientists discover extremely long-lived proteins in aging rats
news-medical.net — “One of the big mysteries in biology is why cells age. Now scientists at the Salk Institute for Biological Studies report that they have discovered a weakness in a component of brain cells that may explain how the aging process occurs in the brain.” View full resource at news-medical.net
Most Recently Shared on February 4, 2012 at 8:44 am By:
Genetics News: Scientists discover extremely long-lived proteins in aging rats: One of the big mysteries in biol... http://t.co/JgzdbIUK
Toxic Solvents Linked to Parkinson's Disease - Neurology (Brain and Nerve) Conditions, Diseases, Medications, Procedures, Tests, Treatment, Prevention, and Prognosis Information on MedicineNet.com
medicinenet.com — “Explains neurology (brain and nerve) conditions; includes symptoms, causes, medications, diagnosis, treatments, prevention, and prognosis information.” View full resource at medicinenet.com
Most Recently Shared on November 15, 2011 at 6:29 pm By:
Eve Glicksman Eldercare Expert
RT @Eldercarexperts Exposure to Toxic Solvents Linked To Parkinson's Disease http://t.co/BYSoE2Pp
Jay Parkinson + MD + MPH = a doctor in NYC (THE “fact” that junk food is cheaper than real...)
blog.jayparkinsonmd.com — “Jay Parkinson + MD + MPH = a doctor in NYC (THE “fact” that junk food is cheaper than real...)” View full resource at blog.jayparkinsonmd.com
Most Recently Shared on September 28, 2011 at 9:34 pm By:
jayparkinson Doctor, Pediatrician, and Physician
Photo: THE “fact” that junk food is cheaper than real food has become a reflexive part of how we explain why... http://t.co/QVJcZpJX
Study Shows How Brain Buys Time For Tough Choices
medicalnewstoday.com — “Some people who receive deep brain stimulation for Parkinson's disease behave impulsively, making quick, often bad, decisions. New research published in Nature Neuroscience explains why, an” View full resource at medicalnewstoday.com
Most Recently Shared on September 27, 2011 at 7:05 am By:
Study Shows How Brain Buys Time For Tough Choices: Some people who receive deep brain stimulation for Parkinson'... http://t.co/EFSDNroS
Finding the perfect balance
epda.eu.com — “Publications, links and resources on Parkinson's disease.” View full resource at epda.eu.com
Most Recently Shared on September 10, 2011 at 9:45 am By:
How 2 deal positively with wearing off in #Parkinson's - Prof. Heinz Reichmann explains (for healthcare professionals): http://t.co/wlQwNoA
Parkinson's in the Media: Addex regains rights to Parkinson's drug candidates from Merck | Parkinson's Action Network
parkinsonsaction.org — “Parkinson's in the Media: Addex regains rights to Parkinson's drug candidates from Merck | Parkinson's Action Network” View full resource at parkinsonsaction.org
Most Recently Shared on September 6, 2011 at 8:12 pm By:
Parkinson'sAction Health Organization
Parkinson's in the Media: Addex regains rights to Parkinson's drug candidates from Merck http://t.co/5d4yq1T
Addex Regains Rights to Parkinson's Drug Candidates from Merck - Drugs.com MedNews
drugs.com — “Geneva, Switzerland, 2 September 2011 - Addex Pharmaceuticals (SIX ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discov” View full resource at drugs.com
Most Recently Shared on September 6, 2011 at 1:14 pm By:
Drugs and Devices OW OW Health
Addex Regains Rights to Parkinson's Drug Candidates from Merck: Geneva, Switzerland, 2 September 2011 - Ad... http://t.co/GgtfT6S #drug
Addex Pharmaceuticals : Addex Regains Rights to Parkinson’s Drug Candidates from Merck
addexpharma.com — “Addex Pharmaceuticals : Addex Regains Rights to Parkinson’s Drug Candidates from Merck” View full resource at addexpharma.com
Most Recently Shared on September 2, 2011 at 4:14 pm By:
Lisa Jarvis Science Enthusiast
Merck hands Addex back rights to mGluR4 compounds in dev for Parkinson's (deal est in '07): http://t.co/NT0jelW
PolygenicBlog: Sharing the Bounty | The Scientist: Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on August 15, 2011 at 4:47 pm By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter PhD, Doctor, Medical Technology, and Pharmacist
Sharing the Bounty | The Scientist: Gut bacteria may be the missing piece that explains the… http://t.co/FcP8ISG
ScienceDirect - Neuroscience : Increased desensitization of dopamine D2 receptor-mediated response in the ventral tegmental area in the absence of adenosine A2A receptors
sciencedirect.com — “ScienceDirect - Neuroscience : Increased desensitization of dopamine D2 receptor-mediated response in the ventral tegmental area in the absence of adenosine A2A receptors” View full resource at sciencedirect.com
Most Recently Shared on August 13, 2011 at 10:09 am By:
Interaction between dopamine and adenosine in the brain may explain the use of A2A antagonists in #Parkinsons. http://t.co/M9W2BL5
Merck Completes Patient Enrollment in SETTLE, a Phase III Pivotal Clinical Trial of Safinamide in Advanced Parkinson?s Disease - Drugs.com MedNews
drugs.com — “Study will evaluate efficacy and safety of safinamide as add-on therapy to a stable dose of levodopa Darmstadt, July 29, 2011 Merck KGaA announced today, that i” View full resource at drugs.com
Most Recently Shared on July 29, 2011 at 3:14 pm By:
Drugs and Devices OW OW Health
Merck Completes Patient Enrollment in SETTLE, a Phase III Pivotal Clinical Trial of Safinamide in Advanced... http://bit.ly/phnf7y #drug
Advertisement
Jim Edwards
@Jim_Edwards
Merck Explains Parkinson's Drug Shortage -- Nearly a Year Later: Almost a year into a shortage of the Parkinson's ... http://bit.ly/bRp1ns
1 year ago...